This research study is evaluating an investigational antiviral treatment to see if it can treat COVID-19 infections.
This is not a vaccine study. This study is being conducted to investigate the safety, tolerability, and potential benefit of an investigational antiviral treatment called zotatifin when given to people with COVID-19. Zotatifin may inhibit the SARS-CoV-2 virus that causes COVID-19.
Any adult age 18 to 64 with mild or moderate COVID-19.
These questions are directed to the person who will participate in the research study if they qualify, so "you" as used in the pre-qualifying questionnaire refers to that person.
No. You may take the pre-qualifying questionnaire just to see if you might pre-qualify. Participation in a research study is completely voluntary at every step in the process.
Why Is This Research Study Important?
Thank you for your interest in joining the growing number of people who have done their part to help the medical community address the COVID-19 pandemic by participating in a research study, also called a clinical trial.
Current management of COVID-19 infections focuses on treating the symptoms. Research studies that seek to find new treatments for COVID-19 are very important. Before new treatments can be approved for public use, they must be tested in research studies like this one.
Although there are many definitions, a clinical research study is generally considered to be health-related clinical research in people with a specific condition using a pre-defined written protocol.
Click here to learn more about clinical research.